nodes	percent_of_prediction	percent_of_DWPC	metapath
Gamma Hydroxybutyric Acid—SLC52A2—blood—hematologic cancer	0.0111	0.0785	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—bone marrow—hematologic cancer	0.0107	0.076	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—hematopoietic system—hematologic cancer	0.00999	0.0707	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—lung—hematologic cancer	0.00973	0.0689	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—testis—hematologic cancer	0.00918	0.065	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—gonad—hematologic cancer	0.0076	0.0537	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—gonad—hematologic cancer	0.00725	0.0513	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—lymph node—hematologic cancer	0.00666	0.0471	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—blood—hematologic cancer	0.00662	0.0468	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—bone marrow—hematologic cancer	0.0064	0.0453	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—blood—hematologic cancer	0.00632	0.0447	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—hematopoietic system—hematologic cancer	0.00607	0.0429	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—lung—hematologic cancer	0.0058	0.0411	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—lung—hematologic cancer	0.00554	0.0392	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—testis—hematologic cancer	0.00547	0.0387	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—testis—hematologic cancer	0.00522	0.037	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—gonad—hematologic cancer	0.00461	0.0326	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—lymph node—hematologic cancer	0.00397	0.0281	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—lymph node—hematologic cancer	0.00379	0.0268	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—lung—hematologic cancer	0.00352	0.0249	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—testis—hematologic cancer	0.00333	0.0235	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—lymph node—hematologic cancer	0.00241	0.0171	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Azacitidine—Pentostatin—hematologic cancer	0.00225	0.192	CbGdCrCtD
Gamma Hydroxybutyric Acid—SLC16A3—Azacitidine—Clofarabine—hematologic cancer	0.002	0.171	CbGdCrCtD
Gamma Hydroxybutyric Acid—SLC16A3—Azacitidine—Nelarabine—hematologic cancer	0.00188	0.161	CbGdCrCtD
Gamma Hydroxybutyric Acid—SLC16A3—Azacitidine—Fludarabine—hematologic cancer	0.00147	0.125	CbGdCrCtD
Gamma Hydroxybutyric Acid—SLC16A3—Azacitidine—Cytarabine—hematologic cancer	0.00139	0.118	CbGdCrCtD
Gamma Hydroxybutyric Acid—SLC16A3—Azacitidine—Gemcitabine—hematologic cancer	0.00139	0.118	CbGdCrCtD
Gamma Hydroxybutyric Acid—SLC16A3—Azacitidine—Cladribine—hematologic cancer	0.00135	0.115	CbGdCrCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IFNA2—hematologic cancer	0.00023	0.00123	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—MTAP—hematologic cancer	0.000228	0.00122	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IL3RA—hematologic cancer	0.000224	0.0012	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Orphan transporters—CREBBP—hematologic cancer	0.000222	0.00119	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—PIK3CB—hematologic cancer	0.000221	0.00119	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—CAMK2D—hematologic cancer	0.000221	0.00119	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000221	0.00119	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.00022	0.00118	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—GRB2—hematologic cancer	0.000216	0.00116	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PDGFA—hematologic cancer	0.000216	0.00116	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—ALB—hematologic cancer	0.000214	0.00115	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000211	0.00113	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000209	0.00112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GMPS—hematologic cancer	0.000208	0.00112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PHYH—hematologic cancer	0.000208	0.00112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—FTCD—hematologic cancer	0.000208	0.00112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ABL1—hematologic cancer	0.000208	0.00112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—H3F3B—hematologic cancer	0.000205	0.0011	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—FGR—hematologic cancer	0.000205	0.0011	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—FHL2—hematologic cancer	0.000203	0.00109	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000202	0.00108	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000202	0.00108	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000202	0.00108	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—AGRN—hematologic cancer	0.000199	0.00107	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—MYB—hematologic cancer	0.000197	0.00106	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ITGAL—hematologic cancer	0.000197	0.00106	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—HGF—hematologic cancer	0.000195	0.00105	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CSF2—hematologic cancer	0.000193	0.00104	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SMPD3—hematologic cancer	0.000191	0.00102	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—IDH2—hematologic cancer	0.000189	0.00101	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HMMR—hematologic cancer	0.000189	0.00101	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—RAC2—hematologic cancer	0.000187	0.00101	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PRKCG—hematologic cancer	0.000186	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—JAK1—hematologic cancer	0.000186	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000185	0.000993	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000182	0.000981	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000182	0.000976	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—hematologic cancer	0.00018	0.000966	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—hematologic cancer	0.000177	0.000954	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—SRC—hematologic cancer	0.000177	0.000953	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ARNTL—hematologic cancer	0.000177	0.000953	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000174	0.000936	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IL2RA—hematologic cancer	0.000174	0.000936	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CA9—hematologic cancer	0.000172	0.000927	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ACP5—hematologic cancer	0.000172	0.000927	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—NRAS—hematologic cancer	0.000171	0.000917	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NCOR2—hematologic cancer	0.00017	0.000915	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—SH2B3—hematologic cancer	0.00017	0.000912	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000169	0.000909	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PDGFB—hematologic cancer	0.000168	0.000903	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—DCK—hematologic cancer	0.000167	0.000896	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ASNS—hematologic cancer	0.000167	0.000896	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—B3GAT1—hematologic cancer	0.000167	0.000896	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CDK2—hematologic cancer	0.000163	0.000876	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—IDH1—hematologic cancer	0.000162	0.000871	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—SPARC—hematologic cancer	0.000162	0.00087	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—TXN—hematologic cancer	0.00016	0.000862	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTO1—hematologic cancer	0.00016	0.000862	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ABCC3—hematologic cancer	0.00016	0.000862	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.00016	0.000858	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000159	0.000857	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HDC—hematologic cancer	0.000158	0.000849	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SPHK1—hematologic cancer	0.000157	0.000843	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—LCK—hematologic cancer	0.000157	0.000842	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—MAPK14—hematologic cancer	0.000156	0.00084	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000155	0.000832	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000154	0.000827	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—H3F3A—hematologic cancer	0.000154	0.000826	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—GATA3—hematologic cancer	0.000152	0.000818	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—FN1—hematologic cancer	0.000152	0.000814	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HSPA5—hematologic cancer	0.000151	0.000814	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—UGT1A1—hematologic cancer	0.000151	0.00081	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000151	0.00081	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PRKCZ—hematologic cancer	0.000149	0.000803	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	0.000149	0.000799	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000147	0.000791	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—KRAS—hematologic cancer	0.000147	0.000789	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC22A1—hematologic cancer	0.000147	0.000788	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CRABP1—hematologic cancer	0.000147	0.000788	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000146	0.000784	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CG—hematologic cancer	0.000145	0.000779	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CDA—hematologic cancer	0.000144	0.000777	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ALOX5—hematologic cancer	0.000143	0.000768	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PTPN11—hematologic cancer	0.000142	0.000766	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—PRKCG—hematologic cancer	0.00014	0.000751	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HDAC2—hematologic cancer	0.000139	0.000748	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PC—hematologic cancer	0.000139	0.000748	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NUP98—hematologic cancer	0.000138	0.000744	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000138	0.000741	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000138	0.00074	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ITGA4—hematologic cancer	0.000138	0.000739	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CD44—hematologic cancer	0.000138	0.000739	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000135	0.000726	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—hematologic cancer	0.000135	0.000725	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CREBBP—hematologic cancer	0.000134	0.000723	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NCOA3—hematologic cancer	0.000134	0.000722	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC35B2—hematologic cancer	0.000134	0.000722	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ADCY7—hematologic cancer	0.000134	0.000722	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GBA—hematologic cancer	0.000134	0.000722	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000134	0.000722	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IL3—hematologic cancer	0.000134	0.000721	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000134	0.000718	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000133	0.000717	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NUP214—hematologic cancer	0.000133	0.000717	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IFNA1—hematologic cancer	0.000133	0.000716	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000133	0.000713	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PTPN1—hematologic cancer	0.000132	0.000709	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—MTR—hematologic cancer	0.000131	0.000702	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ABCG2—hematologic cancer	0.000131	0.000702	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.00013	0.000699	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—RASGRP1—hematologic cancer	0.00013	0.000697	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—SYK—hematologic cancer	0.000129	0.000695	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ENO2—hematologic cancer	0.000128	0.000689	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CD—hematologic cancer	0.000127	0.000685	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ALB—hematologic cancer	0.000126	0.000676	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—HRAS—hematologic cancer	0.000125	0.000671	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTT1—hematologic cancer	0.000124	0.000668	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IFNA2—hematologic cancer	0.000124	0.000667	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MTAP—hematologic cancer	0.000123	0.00066	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SDC1—hematologic cancer	0.000121	0.000653	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3R1—hematologic cancer	0.00012	0.000647	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—JAK2—hematologic cancer	0.000117	0.000629	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—GRB2—hematologic cancer	0.000117	0.000627	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PDGFA—hematologic cancer	0.000116	0.000626	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000116	0.000626	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000116	0.000623	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	0.000116	0.000622	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000113	0.000606	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ABL1—hematologic cancer	0.000112	0.000603	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.000112	0.000601	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CB—hematologic cancer	0.000111	0.000597	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—FHL2—hematologic cancer	0.00011	0.000589	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000109	0.000585	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—AGRN—hematologic cancer	0.000107	0.000577	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HGF—hematologic cancer	0.000105	0.000567	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CSF2—hematologic cancer	0.000104	0.00056	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—CREB1—hematologic cancer	0.000104	0.000556	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NQO1—hematologic cancer	0.000103	0.000555	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CD44—hematologic cancer	0.000103	0.000555	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—BRAF—hematologic cancer	0.000102	0.000549	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IL2—hematologic cancer	0.000102	0.000548	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HMMR—hematologic cancer	0.000102	0.000547	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—IDH2—hematologic cancer	0.000102	0.000547	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PRKCG—hematologic cancer	0.000101	0.000541	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—JAK1—hematologic cancer	0.000101	0.000541	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYCS—hematologic cancer	9.77e-05	0.000525	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.72e-05	0.000523	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HSP90AA1—hematologic cancer	9.71e-05	0.000522	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ARNTL—hematologic cancer	9.57e-05	0.000514	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	9.4e-05	0.000505	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IL2RA—hematologic cancer	9.4e-05	0.000505	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CA9—hematologic cancer	9.31e-05	0.0005	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ACP5—hematologic cancer	9.31e-05	0.0005	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NCOR2—hematologic cancer	9.19e-05	0.000494	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—EP300—hematologic cancer	9.16e-05	0.000492	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PDGFB—hematologic cancer	9.07e-05	0.000488	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—SRC—hematologic cancer	8.9e-05	0.000479	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CDK2—hematologic cancer	8.8e-05	0.000473	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—IDH1—hematologic cancer	8.75e-05	0.000471	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—VEGFA—hematologic cancer	8.67e-05	0.000466	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ABCC3—hematologic cancer	8.66e-05	0.000465	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—TXN—hematologic cancer	8.66e-05	0.000465	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTO1—hematologic cancer	8.66e-05	0.000465	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTP1—hematologic cancer	8.62e-05	0.000463	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—MDM2—hematologic cancer	8.57e-05	0.00046	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—NRAS—hematologic cancer	8.57e-05	0.00046	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SPHK1—hematologic cancer	8.47e-05	0.000455	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—MAPK14—hematologic cancer	8.44e-05	0.000454	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—MAPK3—hematologic cancer	8.2e-05	0.000441	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—FN1—hematologic cancer	8.18e-05	0.00044	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	8.16e-05	0.000439	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ABCB1—hematologic cancer	8.16e-05	0.000438	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—UGT1A1—hematologic cancer	8.14e-05	0.000437	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	8.11e-05	0.000436	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—TGFB1—hematologic cancer	7.96e-05	0.000428	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC22A1—hematologic cancer	7.92e-05	0.000426	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CRABP1—hematologic cancer	7.92e-05	0.000426	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTM1—hematologic cancer	7.92e-05	0.000426	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NCOR1—hematologic cancer	7.92e-05	0.000426	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CG—hematologic cancer	7.83e-05	0.000421	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALOX5—hematologic cancer	7.72e-05	0.000415	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PTPN11—hematologic cancer	7.69e-05	0.000413	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NUP98—hematologic cancer	7.47e-05	0.000402	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—KRAS—hematologic cancer	7.37e-05	0.000396	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CREBBP—hematologic cancer	7.26e-05	0.00039	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ADCY7—hematologic cancer	7.25e-05	0.00039	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NCOA3—hematologic cancer	7.25e-05	0.00039	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NUP214—hematologic cancer	7.2e-05	0.000387	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ABCG2—hematologic cancer	7.06e-05	0.000379	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MTR—hematologic cancer	7.06e-05	0.000379	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—MTHFR—hematologic cancer	7e-05	0.000376	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ENO2—hematologic cancer	6.92e-05	0.000372	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CD—hematologic cancer	6.88e-05	0.00037	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Oedema peripheral—Doxorubicin—hematologic cancer	6.87e-05	0.000104	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Methotrexate—hematologic cancer	6.86e-05	0.000104	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Etoposide—hematologic cancer	6.85e-05	0.000104	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Doxorubicin—hematologic cancer	6.85e-05	0.000104	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Prednisone—hematologic cancer	6.85e-05	0.000104	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Epirubicin—hematologic cancer	6.84e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Doxorubicin—hematologic cancer	6.84e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Dexamethasone—hematologic cancer	6.83e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Betamethasone—hematologic cancer	6.83e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Mitoxantrone—hematologic cancer	6.82e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Irinotecan—hematologic cancer	6.82e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Epirubicin—hematologic cancer	6.81e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Prednisone—hematologic cancer	6.8e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ALB—hematologic cancer	6.79e-05	0.000365	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Epirubicin—hematologic cancer	6.79e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.79e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.79e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Methotrexate—hematologic cancer	6.78e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Dexamethasone—hematologic cancer	6.78e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Betamethasone—hematologic cancer	6.78e-05	0.000103	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CA—hematologic cancer	6.77e-05	0.000364	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Chills—Epirubicin—hematologic cancer	6.76e-05	0.000102	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Prednisone—hematologic cancer	6.74e-05	0.000102	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Betamethasone—hematologic cancer	6.72e-05	0.000102	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Dexamethasone—hematologic cancer	6.72e-05	0.000102	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Prednisone—hematologic cancer	6.71e-05	0.000102	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTT1—hematologic cancer	6.71e-05	0.000361	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Alopecia—Epirubicin—hematologic cancer	6.66e-05	0.000101	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Prednisone—hematologic cancer	6.65e-05	0.000101	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Gemcitabine—hematologic cancer	6.64e-05	0.000101	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Cisplatin—hematologic cancer	6.63e-05	0.0001	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Prednisone—hematologic cancer	6.62e-05	0.0001	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Methotrexate—hematologic cancer	6.61e-05	0.0001	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Epirubicin—hematologic cancer	6.6e-05	9.99e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Cisplatin—hematologic cancer	6.57e-05	9.95e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Cisplatin—hematologic cancer	6.57e-05	9.94e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Epirubicin—hematologic cancer	6.56e-05	9.93e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SDC1—hematologic cancer	6.56e-05	0.000353	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—TP53—hematologic cancer	6.55e-05	0.000352	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Etoposide—hematologic cancer	6.54e-05	9.89e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Prednisone—hematologic cancer	6.53e-05	9.87e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Doxorubicin—hematologic cancer	6.52e-05	9.86e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Doxorubicin—hematologic cancer	6.5e-05	9.84e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3R1—hematologic cancer	6.5e-05	0.000349	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anaemia—Methotrexate—hematologic cancer	6.48e-05	9.8e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Dexamethasone—hematologic cancer	6.48e-05	9.8e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Betamethasone—hematologic cancer	6.48e-05	9.8e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Doxorubicin—hematologic cancer	6.47e-05	9.79e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Epirubicin—hematologic cancer	6.44e-05	9.74e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Betamethasone—hematologic cancer	6.43e-05	9.73e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Dexamethasone—hematologic cancer	6.43e-05	9.73e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Epirubicin—hematologic cancer	6.42e-05	9.72e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Triamcinolone—hematologic cancer	6.38e-05	9.66e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervousness—Epirubicin—hematologic cancer	6.37e-05	9.64e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Epirubicin—hematologic cancer	6.35e-05	9.6e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Doxorubicin—hematologic cancer	6.33e-05	9.57e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—JAK2—hematologic cancer	6.32e-05	0.00034	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Etoposide—hematologic cancer	6.32e-05	9.56e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Epirubicin—hematologic cancer	6.31e-05	9.54e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Doxorubicin—hematologic cancer	6.3e-05	9.53e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Methotrexate—hematologic cancer	6.3e-05	9.53e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Doxorubicin—hematologic cancer	6.28e-05	9.51e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.28e-05	0.000338	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—HRAS—hematologic cancer	6.27e-05	0.000337	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Chills—Doxorubicin—hematologic cancer	6.26e-05	9.47e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Betamethasone—hematologic cancer	6.24e-05	9.45e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Dexamethasone—hematologic cancer	6.24e-05	9.45e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Prednisone—hematologic cancer	6.24e-05	9.44e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Prednisolone—hematologic cancer	6.23e-05	9.43e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Triamcinolone—hematologic cancer	6.22e-05	9.4e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Dexamethasone—hematologic cancer	6.21e-05	9.4e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Betamethasone—hematologic cancer	6.21e-05	9.4e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Cisplatin—hematologic cancer	6.19e-05	9.37e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Prednisone—hematologic cancer	6.19e-05	9.37e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Epirubicin—hematologic cancer	6.18e-05	9.35e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Doxorubicin—hematologic cancer	6.16e-05	9.32e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Prednisone—hematologic cancer	6.15e-05	9.3e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—HRAS—hematologic cancer	6.13e-05	0.00033	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Mental disorder—Doxorubicin—hematologic cancer	6.11e-05	9.24e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Methotrexate—hematologic cancer	6.07e-05	9.19e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Etoposide—hematologic cancer	6.07e-05	9.19e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Doxorubicin—hematologic cancer	6.07e-05	9.18e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Epirubicin—hematologic cancer	6.06e-05	9.17e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Epirubicin—hematologic cancer	6.03e-05	9.12e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Prednisone—hematologic cancer	6.03e-05	9.12e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Etoposide—hematologic cancer	6.02e-05	9.11e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Etoposide—hematologic cancer	6.02e-05	9.1e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CB—hematologic cancer	6e-05	0.000322	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Etoposide—hematologic cancer	5.98e-05	9.05e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Methotrexate—hematologic cancer	5.97e-05	9.03e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Methotrexate—hematologic cancer	5.97e-05	9.03e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Methotrexate—hematologic cancer	5.97e-05	9.03e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Doxorubicin—hematologic cancer	5.96e-05	9.01e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Prednisone—hematologic cancer	5.95e-05	9e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Doxorubicin—hematologic cancer	5.94e-05	8.99e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Prednisolone—hematologic cancer	5.94e-05	8.99e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Prednisolone—hematologic cancer	5.93e-05	8.98e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.93e-05	8.97e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Prednisone—hematologic cancer	5.9e-05	8.93e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Prednisolone—hematologic cancer	5.9e-05	8.93e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervousness—Doxorubicin—hematologic cancer	5.9e-05	8.92e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Epirubicin—hematologic cancer	5.89e-05	8.92e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Epirubicin—hematologic cancer	5.88e-05	8.9e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.88e-05	0.000316	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CG—hematologic cancer	5.88e-05	0.000316	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Back pain—Doxorubicin—hematologic cancer	5.87e-05	8.88e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Prednisone—hematologic cancer	5.85e-05	8.86e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Doxorubicin—hematologic cancer	5.84e-05	8.83e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Epirubicin—hematologic cancer	5.8e-05	8.77e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Methotrexate—hematologic cancer	5.77e-05	8.73e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Epirubicin—hematologic cancer	5.77e-05	8.72e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Triamcinolone—hematologic cancer	5.73e-05	8.67e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Doxorubicin—hematologic cancer	5.72e-05	8.66e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Epirubicin—hematologic cancer	5.68e-05	8.6e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Methotrexate—hematologic cancer	5.68e-05	8.6e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Etoposide—hematologic cancer	5.67e-05	8.58e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Epirubicin—hematologic cancer	5.66e-05	8.57e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Prednisone—hematologic cancer	5.64e-05	8.54e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Betamethasone—hematologic cancer	5.64e-05	8.53e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Dexamethasone—hematologic cancer	5.64e-05	8.53e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Methotrexate—hematologic cancer	5.61e-05	8.49e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Doxorubicin—hematologic cancer	5.61e-05	8.49e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Prednisone—hematologic cancer	5.6e-05	8.47e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Prednisolone—hematologic cancer	5.6e-05	8.47e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Epirubicin—hematologic cancer	5.59e-05	8.45e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Epirubicin—hematologic cancer	5.59e-05	8.45e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Epirubicin—hematologic cancer	5.59e-05	8.45e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Doxorubicin—hematologic cancer	5.58e-05	8.44e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CD44—hematologic cancer	5.58e-05	0.0003	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NQO1—hematologic cancer	5.58e-05	0.0003	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anxiety—Epirubicin—hematologic cancer	5.57e-05	8.42e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Methotrexate—hematologic cancer	5.56e-05	8.41e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.55e-05	8.39e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—AKT1—hematologic cancer	5.53e-05	0.000297	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Methotrexate—hematologic cancer	5.53e-05	8.37e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IL2—hematologic cancer	5.51e-05	0.000296	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Triamcinolone—hematologic cancer	5.51e-05	8.33e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Triamcinolone—hematologic cancer	5.46e-05	8.26e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Epirubicin—hematologic cancer	5.46e-05	8.26e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Triamcinolone—hematologic cancer	5.46e-05	8.26e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Doxorubicin—hematologic cancer	5.45e-05	8.25e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Methotrexate—hematologic cancer	5.45e-05	8.25e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CREBBP—hematologic cancer	5.45e-05	0.000293	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Syncope—Doxorubicin—hematologic cancer	5.44e-05	8.24e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Prednisone—hematologic cancer	5.44e-05	8.23e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Triamcinolone—hematologic cancer	5.43e-05	8.21e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.42e-05	0.000291	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain—Prednisone—hematologic cancer	5.41e-05	8.19e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Epirubicin—hematologic cancer	5.4e-05	8.17e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Betamethasone—hematologic cancer	5.38e-05	8.14e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Dexamethasone—hematologic cancer	5.38e-05	8.14e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Doxorubicin—hematologic cancer	5.36e-05	8.12e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Epirubicin—hematologic cancer	5.35e-05	8.1e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Doxorubicin—hematologic cancer	5.34e-05	8.07e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Epirubicin—hematologic cancer	5.32e-05	8.05e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYCS—hematologic cancer	5.28e-05	0.000284	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Shock—Epirubicin—hematologic cancer	5.27e-05	7.97e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Doxorubicin—hematologic cancer	5.26e-05	7.96e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Epirubicin—hematologic cancer	5.25e-05	7.94e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HSP90AA1—hematologic cancer	5.24e-05	0.000282	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypertension—Doxorubicin—hematologic cancer	5.24e-05	7.93e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.21e-05	7.89e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Epirubicin—hematologic cancer	5.2e-05	7.87e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Betamethasone—hematologic cancer	5.2e-05	7.87e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Dexamethasone—hematologic cancer	5.2e-05	7.87e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Epirubicin—hematologic cancer	5.18e-05	7.83e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Methotrexate—hematologic cancer	5.17e-05	7.83e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CD—hematologic cancer	5.17e-05	0.000278	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Chest pain—Doxorubicin—hematologic cancer	5.17e-05	7.82e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Doxorubicin—hematologic cancer	5.17e-05	7.82e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Doxorubicin—hematologic cancer	5.17e-05	7.82e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Doxorubicin—hematologic cancer	5.15e-05	7.79e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Triamcinolone—hematologic cancer	5.15e-05	7.79e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Methotrexate—hematologic cancer	5.14e-05	7.77e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.13e-05	7.77e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Epirubicin—hematologic cancer	5.1e-05	7.72e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ALB—hematologic cancer	5.1e-05	0.000274	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspnoea—Methotrexate—hematologic cancer	5.1e-05	7.72e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Methotrexate—hematologic cancer	5.09e-05	7.7e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.07e-05	0.000273	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dry mouth—Doxorubicin—hematologic cancer	5.05e-05	7.65e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Prednisone—hematologic cancer	5.04e-05	7.63e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Methotrexate—hematologic cancer	5.04e-05	7.62e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Dexamethasone—hematologic cancer	5e-05	7.56e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Betamethasone—hematologic cancer	5e-05	7.56e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Doxorubicin—hematologic cancer	5e-05	7.56e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Methotrexate—hematologic cancer	4.97e-05	7.52e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Betamethasone—hematologic cancer	4.96e-05	7.5e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Dexamethasone—hematologic cancer	4.96e-05	7.5e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Doxorubicin—hematologic cancer	4.95e-05	7.5e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Betamethasone—hematologic cancer	4.95e-05	7.49e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Dexamethasone—hematologic cancer	4.95e-05	7.49e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—EP300—hematologic cancer	4.94e-05	0.000266	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.94e-05	7.47e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Methotrexate—hematologic cancer	4.93e-05	7.46e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Dexamethasone—hematologic cancer	4.92e-05	7.45e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Betamethasone—hematologic cancer	4.92e-05	7.45e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Doxorubicin—hematologic cancer	4.92e-05	7.45e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Prednisone—hematologic cancer	4.91e-05	7.43e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Methotrexate—hematologic cancer	4.89e-05	7.4e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3R1—hematologic cancer	4.88e-05	0.000262	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.88e-05	7.38e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Doxorubicin—hematologic cancer	4.87e-05	7.37e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Doxorubicin—hematologic cancer	4.86e-05	7.35e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Epirubicin—hematologic cancer	4.84e-05	7.33e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Doxorubicin—hematologic cancer	4.81e-05	7.28e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—SRC—hematologic cancer	4.81e-05	0.000258	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Paraesthesia—Epirubicin—hematologic cancer	4.81e-05	7.27e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Doxorubicin—hematologic cancer	4.79e-05	7.25e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Epirubicin—hematologic cancer	4.77e-05	7.22e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Epirubicin—hematologic cancer	4.76e-05	7.2e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Doxorubicin—hematologic cancer	4.72e-05	7.14e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Methotrexate—hematologic cancer	4.71e-05	7.13e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Epirubicin—hematologic cancer	4.71e-05	7.13e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—HRAS—hematologic cancer	4.7e-05	0.000253	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Prednisone—hematologic cancer	4.68e-05	7.09e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—VEGFA—hematologic cancer	4.68e-05	0.000252	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Methotrexate—hematologic cancer	4.68e-05	7.08e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Dexamethasone—hematologic cancer	4.67e-05	7.06e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Betamethasone—hematologic cancer	4.67e-05	7.06e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Epirubicin—hematologic cancer	4.65e-05	7.04e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTP1—hematologic cancer	4.65e-05	0.00025	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—NRAS—hematologic cancer	4.63e-05	0.000249	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.62e-05	6.99e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Epirubicin—hematologic cancer	4.62e-05	6.98e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Epirubicin—hematologic cancer	4.58e-05	6.93e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Epirubicin—hematologic cancer	4.58e-05	6.93e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Methotrexate—hematologic cancer	4.55e-05	6.88e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Prednisone—hematologic cancer	4.53e-05	6.85e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Methotrexate—hematologic cancer	4.52e-05	6.84e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.51e-05	6.83e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CB—hematologic cancer	4.5e-05	0.000242	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Insomnia—Doxorubicin—hematologic cancer	4.48e-05	6.78e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Doxorubicin—hematologic cancer	4.45e-05	6.73e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—MAPK3—hematologic cancer	4.43e-05	0.000238	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspnoea—Doxorubicin—hematologic cancer	4.42e-05	6.68e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Epirubicin—hematologic cancer	4.41e-05	6.68e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Doxorubicin—hematologic cancer	4.4e-05	6.66e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ABCB1—hematologic cancer	4.4e-05	0.000237	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Epirubicin—hematologic cancer	4.38e-05	6.62e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Doxorubicin—hematologic cancer	4.36e-05	6.6e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Prednisone—hematologic cancer	4.35e-05	6.59e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Prednisone—hematologic cancer	4.32e-05	6.53e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Prednisone—hematologic cancer	4.31e-05	6.52e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Doxorubicin—hematologic cancer	4.31e-05	6.52e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TGFB1—hematologic cancer	4.3e-05	0.000231	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Prednisone—hematologic cancer	4.29e-05	6.49e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.28e-05	6.47e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTM1—hematologic cancer	4.28e-05	0.00023	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NCOR1—hematologic cancer	4.28e-05	0.00023	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Fatigue—Doxorubicin—hematologic cancer	4.27e-05	6.46e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Epirubicin—hematologic cancer	4.25e-05	6.44e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Doxorubicin—hematologic cancer	4.24e-05	6.41e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Doxorubicin—hematologic cancer	4.24e-05	6.41e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Epirubicin—hematologic cancer	4.23e-05	6.4e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Methotrexate—hematologic cancer	4.22e-05	6.38e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Methotrexate—hematologic cancer	4.1e-05	6.21e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Doxorubicin—hematologic cancer	4.08e-05	6.18e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Prednisone—hematologic cancer	4.07e-05	6.15e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.05e-05	6.13e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—KRAS—hematologic cancer	3.98e-05	0.000214	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Epirubicin—hematologic cancer	3.94e-05	5.97e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Doxorubicin—hematologic cancer	3.94e-05	5.95e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Doxorubicin—hematologic cancer	3.92e-05	5.93e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Methotrexate—hematologic cancer	3.91e-05	5.92e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTEN—hematologic cancer	3.89e-05	0.000209	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Epirubicin—hematologic cancer	3.84e-05	5.81e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Methotrexate—hematologic cancer	3.78e-05	5.72e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MTHFR—hematologic cancer	3.78e-05	0.000203	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—EP300—hematologic cancer	3.71e-05	0.0002	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Epirubicin—hematologic cancer	3.66e-05	5.54e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CA—hematologic cancer	3.66e-05	0.000197	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Doxorubicin—hematologic cancer	3.65e-05	5.52e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Methotrexate—hematologic cancer	3.64e-05	5.5e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Methotrexate—hematologic cancer	3.61e-05	5.46e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Methotrexate—hematologic cancer	3.6e-05	5.45e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Methotrexate—hematologic cancer	3.58e-05	5.42e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Doxorubicin—hematologic cancer	3.55e-05	5.38e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Epirubicin—hematologic cancer	3.54e-05	5.36e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TP53—hematologic cancer	3.54e-05	0.00019	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Epirubicin—hematologic cancer	3.4e-05	5.15e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Methotrexate—hematologic cancer	3.4e-05	5.14e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Doxorubicin—hematologic cancer	3.39e-05	5.13e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HRAS—hematologic cancer	3.38e-05	0.000182	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Epirubicin—hematologic cancer	3.38e-05	5.11e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Epirubicin—hematologic cancer	3.37e-05	5.1e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Epirubicin—hematologic cancer	3.35e-05	5.07e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Doxorubicin—hematologic cancer	3.28e-05	4.96e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Epirubicin—hematologic cancer	3.18e-05	4.81e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CG—hematologic cancer	3.17e-05	0.000171	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Doxorubicin—hematologic cancer	3.15e-05	4.77e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Doxorubicin—hematologic cancer	3.12e-05	4.73e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Doxorubicin—hematologic cancer	3.12e-05	4.72e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Doxorubicin—hematologic cancer	3.1e-05	4.7e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—AKT1—hematologic cancer	2.99e-05	0.000161	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CREBBP—hematologic cancer	2.94e-05	0.000158	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Doxorubicin—hematologic cancer	2.94e-05	4.45e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CD—hematologic cancer	2.79e-05	0.00015	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALB—hematologic cancer	2.75e-05	0.000148	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CA—hematologic cancer	2.75e-05	0.000148	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3R1—hematologic cancer	2.64e-05	0.000142	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CB—hematologic cancer	2.43e-05	0.000131	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—AKT1—hematologic cancer	2.24e-05	0.000121	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTEN—hematologic cancer	2.1e-05	0.000113	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—EP300—hematologic cancer	2e-05	0.000108	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CA—hematologic cancer	1.48e-05	7.97e-05	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—AKT1—hematologic cancer	1.21e-05	6.51e-05	CbGpPWpGaD
